Company Overview of Mission Pharmacal Company, Inc.
Mission Pharmacal Company, Inc., a pharmaceutical company, develops and manufactures prescription medications and over-the-counter products in therapeutic areas of women's health, pediatric, urology, and dermatology. The company’s products include CitraNatal, a prescription prenatal vitamin that provides nutrition for preconception, pregnancy, and lactation in various formulations customized for individual patient needs; Urocit-K, a potassium citrate indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of etiology, and uric acid lithiasis with or without calcium stones; Lithostat (acetohydroxamic acid) for use as an adjunc...
10999 Interstate Highway 10 West
San Antonio, TX 78230-1355
Founded in 1946
Key Executives for Mission Pharmacal Company, Inc.
President of Commercial Operations
Senior Director of Consumer Marketing
Compensation as of Fiscal Year 2015.
Mission Pharmacal Company, Inc. Key Developments
Mission Pharmacal Relaunches Product to Help Kidney Stone Patients
Sep 10 15
Mission Pharmacal Company announced the reintroduction of Lithostat® (acetohydroxamic acid) for use as an adjunctive therapy with antibiotic therapy for struvite (infection) kidney stones. As of September 7, Mission is again offering this product with significant improvements in service for the patients who rely on it and their healthcare providers.
Mission Pharmacal Company and Europa Sports Products of Charlotte Sign Distribution Agreement for COMPETE Energy Bites
Nov 6 14
Mission Pharmacal Company and Europa Sports Products of Charlotte signed an agreement effective as of September 17 for Europa to distribute Mission's COMPETE energy bites to fitness centers and select other retail outlets nationally. This dietary supplement provides 135 mg. of energy-boosting caffeine or the equivalent of a 12 oz. cup of premium coffee in a great-tasting chew. They offer a bite-sized punch of power to enhance performance and fight fatigue. With only 45 calories, COMPETE energy bites eliminate the need to consume chalky energy bars or medicinal-tasting energy drinks. COMPETE energy bites were successfully test marketed in leading fitness centers and health clubs, including Bally Total Fitness(TM), Crunch Fitness, and XSport Fitness facilities, in New York City, Los Angeles, and Chicago during the second half of 2013 and early 2014. More than 100 facilities already offer COMPETE in these three major test markets, and additional outlets and markets are being added quickly through the agreement with Europa. COMPETE energy bites have been developed and introduced by West Dakota, LLC, Mission's marketing partner in the United States. While the U.S. is the current area of focus for COMPETE energy bites, Mission Pharmacal is committed to broadening this footprint and also seeks international partnership opportunities. This is evidenced by a successful U.K. pilot and current product rollout for COMPETE energy bites and a recent distribution agreement between Mission and West Dakota, U.K. Limited, to further expand in the U.K.
Retrophin, Inc. Enters into a First Amendment to Trademark License and Supply Agreement with Mission Pharmacal Company
Jul 29 14
On July 28, 2014, Retrophin, Inc. entered into a First Amendment to Trademark License and Supply Agreement with Mission Pharmacal Company to amend the Trademark License & Supply Agreement, made effective as of May 29, 2014, between Mission and the Company. The First Amendment revises the territory covered by the Agreement, at no additional cost or expense, to include the United States and Canada, as allowed by Canadian regulations for compassionate use.
Similar Private Companies By Industry
Recent Private Companies Transactions